BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 11989561)

  • 1. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
    Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
    Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Delayed orchiectomy and surgery of metastases after primary chemotherapy in the treatment of advanced testicular tumors].
    Ondrus D; Hornák M; Schnorrer M; Mat'oska J
    Rozhl Chir; 2001 Nov; 80(11):612-4. PubMed ID: 11794064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer.
    Ondrus D; Hornák M; Matoska J
    Neoplasma; 1993; 40(3):189-92. PubMed ID: 7688871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
    Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
    J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stage I yolk sac tumor of testis in children younger than 2 years, chemotherapy or not?
    Liu HC; Liang DC; Chen SH; Liu FL; Chang PY; Sheu JC; Wang NL
    Pediatr Hematol Oncol; 1998; 15(3):223-8. PubMed ID: 9615319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of postchemotherapy adjunctive retroperitoneal lymph node dissection in non-seminomatous germ cell cancer patients.
    Goepel M; Recker F; Otto T; Krege S; Rübben H
    Urol Int; 1996; 57(4):209-12. PubMed ID: 8961487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors.
    Eskicorapci SY; Ekici S; Atsu MN; Dogan R; Ozen H
    Int J Urol; 2004 Aug; 11(8):634-9. PubMed ID: 15285754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
    Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
    Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H; Ghozzi S; Ramzi K; Smaali CH; Majed H; Ben Rais N
    Tunis Med; 2005 Dec; 83 Suppl 12():78-83. PubMed ID: 16430075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of germ cell testicular cancer with pulmonary metastases.
    Schnorrer M; Ondrus D; Cársky S; Hornák M; Belan V; Kausitz J; Matośka J
    Neoplasma; 1996; 43(1):47-50. PubMed ID: 8843960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.